mechlorethamine has been researched along with isotretinoin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cabanillas, FF; Duvic, M; Eifel, PJ; Kurzrock, R; Lemak, NA; Redman, JR; Tucker, SL | 1 |
1 review(s) available for mechlorethamine and isotretinoin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for mechlorethamine and isotretinoin
| Article | Year |
|---|---|
Combined modality therapy for cutaneous T-cell lymphoma.
Topics: Administration, Cutaneous; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Cause of Death; Combined Modality Therapy; Disease-Free Survival; Female; Follow-Up Studies; Humans; Interferon Type I; Isotretinoin; Keratolytic Agents; Male; Mechlorethamine; Middle Aged; Mycosis Fungoides; Neoplasm Staging; Radiotherapy Dosage; Radiotherapy, High-Energy; Recombinant Proteins; Remission Induction; Sezary Syndrome; Skin Neoplasms; Survival Rate | 1996 |